Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Cardiology Reports
Erschienen in: Current Cardiology Reports 9/2018

01.09.2018 | Congenital Heart Disease (RA Krasuski, Section Editor)

Preoperative Evaluation of Adult Congenital Heart Disease Patients for Non-cardiac Surgery

verfasst von: Jennifer F. Gerardin, Michael G. Earing

Erschienen in: Current Cardiology Reports | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Highlight the extracardiac comorbidities that adult congenital heart disease patients and summarize the current recommendations for non-cardiac surgery.

Recent Findings

Adult congenital heart disease patients are living longer, becoming more complex and developing adult comorbidities as they age. These patients have multiorgan involvement including higher prevalence of kidney disease and decreased lung function. Non-cardiac comorbidities can complicate surgery in this patient population. Most patients have non-cardiac surgery in community settings. These settings may increase adverse events during and in the post-operative period. Survival is improved when moderate and complex patients are seen in regional referral centers.

Summary

Improved awareness of long-term complications of congenital heart disease and extracardiac comorbidities for adult congenital heart disease patients is needed. Appropriate care settings with both congenital heart disease expertise and adult subspecialty care reduces morbidity and mortality in these complex patients.
Literatur
1.
•• Gilboa S, Devine OJ, Kucik JE, Oster ME, Reihle-Colarusso T, Nembhard WN, et al. Congenital heart defects in the United States estimating the magnitude of the affected population in 2010. Circulation. 2016;134:101–9. Estimation of US population based on current population and the Canadian prevalence of congenital heart disease. CrossRefPubMedPubMedCentral
2.
Gurvitz M, Valente AM, Broberg C, Cook S, Stout K, Kay J, et al. Prevalence and predictors of gaps in care among adult congenital heart disease patients HEART-ACHD (the health, education, and access research trial). J Am Coll Cardiol. 2013;61:2180–4.CrossRefPubMedPubMedCentral
3.
• Gerardin JF, Menk JS, Pyles LA, Martin CM, Lohr JL. Compliance with adult congenital heart disease guidelines: are we following the recommendations? Congenit Heart Dis. 2016;11(3):245–53. Large single-center retrospective study demonstrating differences between pediatric, adult and adult congenital cardiologist compliance with adult congenital heart disease guidelines. CrossRefPubMed
4.
Afilalo J, Therrien J, Pilote L, Ionescu-Ittu R, Martucci G, Marelli AJ. Geriatric congenital heart disease burden of disease and predictors of mortality. J Am Coll Cardiol. 2011;58:1509–15.CrossRefPubMed
5.
• Mazor Dray E, Marelli AJ. Adult congenital heart disease: scope of the problem. Cardiol Clin. 2015;33:503–12. A large Canadian study documenting an increase in the median age of and severity of adult congenital heart disease patients. CrossRefPubMed
6.
Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115:163–72.CrossRefPubMed
7.
Billett J, Cowie MR, Gatzoulis MA, Vonder Muhll IF, Majeed A. Comorbidity, healthcare utilisation and process of care measures in patients with congenital heart disease in the UK: cross-sectional, population-based study with case- control analysis. Heart. 2008;94:1194–9.CrossRefPubMed
8.
Maxwell BG, Wong JK, Kin C, Lobato RL. Perioperative outcomes of major noncardiac surgery in adults with congenital heart disease. Anesthesiology. 2013;119:762–9.CrossRefPubMed
9.
• Agarwal S, Sud K, Menon V. Nationwide hospitalization trends in adult congenital heart disease across 2003–2012. J Am Heart Assoc. 2016;5(1):1–12. National retrospective population study analyzing hospital admissions identifying increasing costs in ACHD admissions. CrossRef
10.
Rodriguez FH, Moodie DS, Parekh DR, Franklin WJ, Morales DL, Zafar F, et al. Outcomes of heart failure – related hospitalization in adults with congenital heart disease in the United States. Congenit Heart Dis. 2013;8:513–9.CrossRefPubMed
11.
• Bhatt AB, Rajabali A, He W, Benavidez OJ. High resource use among adult congenital heart surgery admissions in adult hospitals: risk factors and association with death and comorbidities. Congenit Heart Dis. 2015;10:13–20. Retrospective population study that analyzed national inpatient and surgical databases that identifies risk factors for poor outcomes. CrossRefPubMed
12.
•• Lui GK, Saidi A, Bhatt AB, Burchill LJ, Deen JF, Earing MG et al. On behalf of the American Heart Association Adult Congenital Heart Disease Committee of the Council on Clinical Cardiology and Council on Cardiovascular Disease in the Young; Council on Cardiovascular Radiology and Intervention; and Council on Quality of Care and Outcomes Research. Diagnosis and management of noncardiac complications in adults with congenital heart disease. A scientific statement from the American Heart Association. Circulation. 2017; 136: 00–00. Comprehensive scientific statement on noncardiac manifestations of adult congenital heart disease patients that outlines preoperative evaluation.
13.
Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to develop guidelines on the Management of Adults with congenital heart disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(23):e143–263.CrossRefPubMed
14.
Marelli A, Beauchesne L, Mital S, Therrien J, Silversides CK. Canadian cardiovascular society 2009 consensus conference on the management of adults with congenital heart disease: introduction. Can J Cardiol. 2010;26(3):e65–9.CrossRefPubMed
15.
Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31:2915–57.CrossRefPubMed
16.
Everitt IK, Gerardin JF, Rodriguez FH, Book WM. Improving the quality of transition and transfer of care in young adults with congenital heart disease. Congenit Heart Dis. 2017;12:242–50.CrossRefPubMed
17.
Ermis P, Dietzman T, Franklin W, Kim J, Moodie D, Parekh D. Cardiac resource utilization in adults at a freestanding children’s hospital. Congenit Heart Dis. 2014;9:178–86.CrossRefPubMed
18.
Kogon B, Rosenblum J, Alsoufi B, Shashidharan S, Book W. The evolution of an adult congenital heart surgery program: the Emory system. Semin Thorac Cardiovasc Surg Pediatr Card Surg Ann. 2017;20:28–32.CrossRef
19.
Mylotte D, Pilote L, Ionescu-Ittu, Abrahamowicz M, Khairy P, Therrien J, et al. Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation. 2014;129(18):1804–12.CrossRefPubMed
20.
Maxwell BG, Maxwell TG, Wong JK. Decentralization of care for adults with congenital heart disease in the United States: a geographic analysis of outpatient surgery. PLoS One. 2014;9(9):e106730.CrossRefPubMedPubMedCentral
21.
Maxwell BG, Wong JK, Lobato RI. Perioperative morbidity and mortality after noncardiac surgery in young adults with congenital or early acquired heart disease: a retrospective cohort analysis of the national. Surgical quality improvement program database. Am Surg. 2014;80(4):321–6.PubMed
22.
• Maxwell BG, Posner KL, Wong JK, Oakes DA, Kelly NE, Domino KB, et al. Factors contributing to adverse perioperative events in adults with congenital heart disease: a structured analysis of cases from the closed claims project. Congenit Heart Dis. 2015;10:21–9. Retrospective analysis of adverse event cases within the Anesthesia Closed Claim Project database for ACHD noncardiac surgeries. CrossRefPubMed
23.
•• Stout KK, Broberg CS, Book WM, Cecchin F, Chen JM, Dimopoulos K, et al. Chronic heart failure in congenital heart disease. A scientific statement from the American Heart Association. Circulation. 2016;133:770–801. A scientific statement from the AHA that outlines the current treatment strategies for treatment of heart failure in adult congenital heart disease patients. PubMedCrossRef
24.
• Engelings CC, Helm PC, Abdul-Khaliq H, Boulos Asfour B, Bauer UM, Baumgartner H, et al. Cause of death in adults with congenital heart disease—an analysis of the German National Register for congenital heart defects. Int J Cardiol. 2016;211:31–6. National German register study evaluating the most common cause of death in adult congenital patients. CrossRefPubMed
25.
Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the pediatric and congenital electrophysiology society (PACES) and the Heart Rhythm Society (HRS). Heart Rhythm. 2014;11:e102–65.CrossRefPubMed
26.
Aleksei A, Filippov AA, del Nido PJ, Vasilyev NV. Management of systemic right ventricular failure in patients with congenitally corrected transposition of the great arteries. Circulation. 2016;134:1293–302.CrossRef
27.
•• Bhatt AB, Foster E, Kuehl K, Alper J, Brabeck S, Crumb S, et al. Congenital heart disease in the older adult: A scientific statement from the American Heart. Association. Circulation. 2015;131(21):1884–931. Scientific statement from the AHA discussing the cardiac and noncardiac manifestations of congenital heart disease patients older than 40 years old. CrossRefPubMed
28.
Giannakoulas G, Dimopoulos K, Engel R, Goktekin O, Kucukdurmaz Z, Vatankulu MA, et al. Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors. Am J Cardiol. 2009;103(10):1445–50.CrossRefPubMed
29.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:2440–92.CrossRefPubMed
30.
Flanagan MF, Hourihan M, Keane JF. Incidence of renal dysfunction in adults with cyanotic congenital heart disease. Am J Cardiol. 1991 Aug 1;68(4):403–6.CrossRefPubMed
31.
Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117:2320–8.CrossRefPubMed
32.
• Sharma S, Ruebner RL, Furth SL, Dodds KM, Rychik J, Goldberg DJ. Assessment of kidney function in survivors following Fontan palliation. Congenit Heart Dis. 2016;11:630–6. Single center retrospective study that evaluates the prevalence of kidney disease in the Fontan population. CrossRefPubMed
33.
Moons P, Van Deyk K, Dedroog D, Troost E, Budts W. Prevalence of cardiovascular risk factors in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil. 2006;13(4):612–6.CrossRefPubMed
34.
Hager A, Kanz S, Kaemmerer H, Schreiber C, Hess J. Coarctation long-term assessment (COALA): significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material. J Thorac Cardiovasc Surg. 2007;134:738–45.CrossRefPubMed
35.
Ginde S, Bartz PJ, Hill GD, Danduran MJ, Biller J, Sowinski J, et al. Restrictive lung disease is an independent predictor of exercise intolerance in the adult with congenital heart disease. Congenit Heart Dis. 2013;8:246–54.CrossRefPubMed
36.
• Cohen KE, Buelow MW, Dixon J, Brazauskas R, Cohen SB, Earing MG et al. Forced vital capacity predicts morbidity and mortality in adults with repaired tetralogy of Fallot Congenit Heart Dis 2017; 00: 1–6. Single center retrospective study demonstrating decreased force vital capacity in adult tetralogy of Fallot patients.
37.
Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:e278–333.CrossRefPubMed
38.
Wang A, Book WM, McConnell M, Lyle T, Rodby K, Mahle WT. Prevalence of hepatitis C infection in adult patients who underwent congenital heart surgery prior to screening in 1992. Am J Cardiol. 2007;100(8):1307–9.CrossRefPubMed
39.
Cox DA, Ginde S, Tweddell JS, Earing MG. Outcomes of a hepatitis C screening protocol in at risk adults with prior cardiac surgery. World J Pediatr Congenit Heart Surg. 2014;5(4):503–6.CrossRefPubMed
40.
•• Daniels CJ, Bradley EA, Landzberg MJ, Aboulhosn J, Beekman RH 3rd, Book W, et al. Fontan-associated liver disease: Proceedings from the American College of Cardiology Stakeholders meeting, October 1 to 2, 2015, Washington DC. J Am Coll Cardiol. 2017;70(25):3173–94. Summary of ACC stakeholders meeting that defined and summarized Fontan associated liver disease. CrossRefPubMed
41.
• Wu FM, Kogon B, Earing MG, Aboulhosn JA, Broberg CS, John AS et al. for the Alliance for Adult Research in Congenital Cardiology (AARCC) Investigators. Liver health in adults with Fontan circulation: a multicenter cross-sectional study. J Thorac Cardiovasc Surg. 2017; 153: 656–64. Multicenter study demonstrating a high prevalence of liver disease in Fontan patients.
42.
• Elder RW, McCabe NM, Veledar E, Kogon BE, Jokhadar M, Rodriguez FH, et al. Risk factors for major adverse events late after Fontan palliation. Congenit Heart Dis. 2015;10:159–68. Single center study that developed scoring system to evaluate liver disease and portal hypertension in Fontan patients that predicts adverse outcomes. CrossRefPubMed
43.
•• Marelli A, Miller SP, Marino BS, Jefferson AL, Newburger JW. Brain in congenital heart disease across the lifespan; the cumulative burden of injury. Circulation. 2016;133:1951–62. A comprehensive review of neurodevelopmental delays in CHD and acquired cognitive deficits as these patients age. CrossRefPubMedPubMedCentral
44.
Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW, et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012;126:1143–72.CrossRefPubMed
45.
Hebson C, Book W, Elder RW, Ford R, Jokhadar M, Kanter K et al. “Frontiers in Fontan failure: a summary of conference proceedings” Congenit Heart Dis 2016; 00–00.
46.
Gerardin J, Rodriguez F, Saraf A, Book WM. Heart transplantation in adults for Fontan failure. Prog Pediatr Cardiol. 2016;42:17–22.CrossRef
47.
McClain CD, McGowan FX, Kovatsis PG. Laparoscopic surgery in a patient with Fontan physiology. Anesth Analg. 2006;103:856–8.CrossRefPubMed
48.
McCrindle BW, Manlhiot C, Cochrane A, Roberts R, Hughes M, Szechtman B, et al. Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure. J Am Coll Cardiol. 2013;61:346–53.CrossRefPubMed
49.
Mori M, Aguirre AJ, Elder RW, Kashkouli A, Farris AB, Ford RM, et al. Beyond a broken heart: circulatory dysfunction in the failing Fontan. Pediatr Cardiol. 2014;35:569–79.CrossRefPubMed
50.
d’Udekem Y, Iyengar AJ, Galati JC, Forsdick V, Weintraub RG, Wheaton GR, et al. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation. 2014;130:S32–8.CrossRefPubMed
51.
• Book WM, Gerardin J, Saraf A, Valente AM, Rodriguez FH. Clinical phenotypes of Fontan failure: implications for management. Congenit Heart Dis. 2016;11(4):296–308. A review article that proposed a new classification system for Fontan failure. CrossRefPubMed
52.
Rabbitts JA, Groenewald CB, Mauermann WJ, Barbara DW, Burkhart HM, Warnes CA, et al. Outcomes of general anesthesia for noncardiac surgery in a series of patients with Fontan palliation. Paediatr Anaesth. 2013;23(2):180–7.CrossRefPubMed
53.
•• Abman SH, Hansmann G, Archer S, Ivy D, Adatia I, Chung WK, et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015;132:2037–99. New pediatric cardiology pulmonary hypertension guidelines that discusses treatment for Eisenmenger syndrome. CrossRefPubMed
54.
Hopkins WE, Ochoa LL, Richardson GW, Trulock EP. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant. 1996;15:100–5.PubMed
55.
• Opotowsky AR. Clinical evaluation and management of pulmonary hypertension in the adult with congenital heart disease. Circulation. 2015;131:200–10. A comprehensive review of pulmonary hypertension management in ACHD patients. CrossRefPubMed
56.
Ammash N, Warnes CA. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol. 1996;28:768–72.CrossRefPubMed
57.
Niwa K, Perloff JK, Kaplan S, Child JS, Miner PD. Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol. 1999;34:223–32.CrossRefPubMed
58.
Cannesson M, Earing MG, Collange V, Kersten JR. Anesthesia for noncardiac surgery in adults with congenital heart disease. Anesthesiology. 2009;111:432–40.CrossRefPubMed
59.
Dittrich S, Haas NA, Bührer C, Müller C, Dähnert I, Lange PE. Renal impairment in patients with long-standing cyanotic congenital heart disease. Acta Paediatr. 1998;87:949–54.CrossRefPubMed
60.
Raines DE, Liberthson RR, Murray JR. Anesthetic management and outcome following noncardiac surgery in nonparturients with Eisenmenger’s physiology. J Clin Anesth. 1996;8:341–7.CrossRefPubMed
61.
Ammash NM, Connolly HM, Abel MD, Warnes CA. Noncardiac surgery in Eisenmenger syndrome. J Am Coll Cardiol. 1999;33:222–7.CrossRefPubMed
62.
Joyce JA. Update for nurse anesthetists. Eisenmenger syndrome: an anesthetic conundrum. Am Assoc Nurse Anesth J 2006;74(3):233–9.
63.
Bennett JM, Ehrenfeld JM, Markham L, Eagle SS. Anesthetic management and outcomes for patients with pulmonary hypertension and intracardiac shunts and Eisenmenger syndrome: a review of institutional experience. J Clin Anesth. 2014;24(4):286–93.CrossRef
Metadaten
Titel
Preoperative Evaluation of Adult Congenital Heart Disease Patients for Non-cardiac Surgery
verfasst von
Jennifer F. Gerardin
Michael G. Earing
Publikationsdatum
01.09.2018
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 9/2018
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-018-1016-5

Weitere Artikel der Ausgabe 9/2018

Current Cardiology Reports 9/2018 Zur Ausgabe

Congenital Heart Disease (RA Krasuski, Section Editor)

Resynchronization Therapy for Patients with Congenital Heart Disease: Are We Ready for Prime Time?

Heart Failure (H Eisen, Section Editor)

Complications of Cardiac Transplantation

Public Health Policy (E Klodas, Section Editor)

Coronary Artery Calcium Score: the “Mammogram” of the Heart?

Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Cardiovascular Risk Assessment in Patients with Hypertriglyceridemia

Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

An Overview of Clinical Outcomes in Transvenous and Subcutaneous ICD Patients

Peripheral Vascular Disease (CJ Cooper and R Gupta, Section Editors)

Preventing Major Amputations in Patients with Critical Limb Ischemia

Neu im Fachgebiet Kardiologie

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise